MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide additional benefit to people living with relapsing multiple sclerosis The trial ...

Approval was based on improved survival outcomes vs platinum-based chemotherapy as demonstrated in the phase 3 NIAGARA study.

NORCROSS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...

Seven-year follow-up data of a multicenter, randomized phase 2 study evaluating the treatment of melanoma brain metastases shows ipilimumab plus nivolumab is an effective long-term care option. First ...

Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Regulus Therapeutics' Phase 1b study shows farabursen 300 mg slowed kidney volume growth in ADPKD patients with a favorable ...

The Comet bags the affordability crown thanks to its Rs 6.99 lakh-9.83 lakh price range, and buyers can additionally shave off at least Rs 2 lakh by opting for MG's battery-as-a-service program.

Samantha Ruth Prabhu, who often shares glimpses of her intense workout routines, recently posted a video of herself performing a hip thrust with an impressive 110 kg on her Instagram stories. The ...

Fitness coach, who lost 89 kg during her impressive transformation from 154 kg to 65 kg, shared the diet plan she followed. Several factors and lifestyle changes contribute to weight loss.